PERSONAL DE APOYO
ROSSI AndrÉs Hugo
artículos
Título:
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
Autor/es:
ROUCO, SANTIAGO OVIEDO; RODRIGUEZ, PAMELA E; MIGLIETTA, ESTEBAN A; RALL, PABLO; LEDESMA, MARÍA M GONZALEZ LOPEZ; VARESE, AUGUSTO; PASCUALE, CARLA A; OJEDA, DIEGO S; MAZZITELLI, BIANCA; SANCHEZ, LAUTARO; CEBALLOS, ANA; PEREZ, EDUARDO; GEFFNER, JORGE; MIRAGAYA, YANINA; ROSSI, ANDRÉS H; GAMARNIK, ANDREA V
Revista:
LANCET INFECTIOUS DISEASES
Editorial:
ELSEVIER SCIENCE INC
Referencias:
Año: 2022 vol. 22 p. 1118 - 1119
ISSN:
1473-3099
Resumen:
With the surge of new SARS-CoV-2 variants, countries have begun offering COVID-19 vaccine boosterdoses to high-risk groups and, more recently, to the adult population in general. However, uncertainty remains over how long primary vaccination series remain effective, the ideal timing for booster doses, and the safety of heterologous booster regimens. We aimed to investigate COVID-19 primary vaccine series effectiveness and its waning, and the safety and effectiveness of booster doses, in a UK community setting.
